Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Adipocyte-Derived Exosomal miR-5099 Mitigates M1 Macrophage Polarization and Adipose Inflammation via c-Met/NF-κB Axis to Improve Metabolic Health

Tang P., Tai L., Xu H., Zhu D., Li J., Feng H.

Animal Study on Systemic / IV, published in Adv Sci (Weinh) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adv Sci (Weinh) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41722058
PMCID
PMC13116018
DOI
10.1002/advs.202518902

Abstract (original English)

Obesity underlies metabolic dysfunction and contributes to the pathogenesis of various diseases. Obesity associated adipose tissue (AT) inflammation contributes to whole body inflammation vulnerability and metabolic disease development. Celastrol (CEL) exhibits significant therapeutic potential against obesity; however, its clinical application is limited by toxicity. Here, CEL treatment fundamentally reprograms the microRNA (miRNA) profile of adipocyte-derived exosomes. Among the altered miRNAs, we identified miR-5099 as being dramatically upregulated and enriched specifically within adipocyte-derived exosomes. We found that CEL-conditioned adipocyte culture medium exhibited the beneficial effects, including the suppression of M1 macrophage polarization, improvement of metabolic function, and reduction of inflammation in obese animals. Importantly, these beneficial effects are largely dependent on the presence of exosomal miR-5099. Furthermore, direct administration of miR-5099 in obese mice significantly ameliorated metabolic disorders, including adipose tissue inflammation and hepatic steatosis. Mechanistically, miR-5099 attenuates AT inflammation by directly targeting the c-Met/NF-κB axis in infiltrated macrophages. Concomitantly, miR-5099 enhances systemic insulin sensitivity and glucose homeostasis across metabolic tissues. Collectively, our study identifies miR-5099 as t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdipocytesMacrophagesAnimalsMice, Inbred C57BLMiceObesityInflammationNF-kappa BMicroRNAs

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research